Trials / Completed
CompletedNCT02362399
Effect of Sildenafil Citrate on Uteri- Placental Perfusion, Doppler Indices in Growth Restricted Fetuses
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Al Hayat National Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
To detect the effect of sildenafil citrate on Doppler parameters in fetuses suffering from growth restriction to support its use later as prolonged therapy in those pregnancies at higher risk for such complication.
Detailed description
Participants were randomized in 1:1 ratio into one of the following drug regime: Group (I): "sildenafil citrate group" This group consisted of 22 women who received single oral dose of 50 mg sildenafil citrate. Group (II): "placebo group" This group consisted of 22 women who received single oral dose of placebo. All participants were evaluated by ultrasound once they admitted and again after 2-hours following administration of either of the treatment tablets. One sonographer was allocated to evaluate all mothers included in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sildenafil citrate | single oral dose of 50 mg |
| OTHER | placebo | single oral dose of placebo tablet |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2015-02-12
- Last updated
- 2016-04-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02362399. Inclusion in this directory is not an endorsement.